BUY Aster DM Healthcare Limited — IDBI Capital
byIDBI CapitalHorizon: NA (inferred 1–3 months)30 Jul 2026via IDBI Capital Research Calls Telegram
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
CRISIL has assigned credit ratings to Aster DM Quality Care Ltd's bank facilities: AA+/Stable for long-term (860.50 crore) and A1+ for short-term (assigned). These ratings were novated following the c
BSE · Company Update·30 Jul · today
Dr. Azad Moopen Meets Shri D.K. Shivakumar; Reaffirms Aster DM Quality Cares Commitment to Karnataka with Rs 1,315 Crore Investment
NewsGoogle News·25 Jul · 5d ago
Aster DM Healthcare का बड़ा दांव: कर्नाटक में ₹1,315 करोड़ का होगा ज़ोरदार एक्सपेंशन!
NewsGoogle News·25 Jul · 5d ago
Aster DM Healthcare Share Price: કર્ણાટકમાં ₹1,315 કરોડનું જંગી રોકાણ, નવા Hopsital બનશે
NewsGoogle News·25 Jul · 5d ago
Aster DM Healthcare Plans ₹1,315 Crore Expansion in Karnataka
NewsGoogle News·25 Jul · 5d ago
Aster DM Healthcare to rename as Aster DM Quality Care Limited
NewsGoogle News·25 Jul · 5d ago
Aster DM Healthcare Ltd has provided an intimation of its revised credit rating.
BSE · Company Update·10 Jul · 3w ago
Aster DM Healthcare Limited announced changes in its Board of Directors, Key Managerial Personnel (KMP), Senior Managerial Personnel (SMP), and revised its Employee Stock Option Plan (ESOP) scheme.
NSE · Outcome of Board Meeting·1 Jul · 4w ago
Aster DM Healthcare Ltd's Board Meeting outcome on July 1, 2026, included changes in Directors, KMPs, SMPs, and approval of an ESOP Plan.
BSE · Others·1 Jul · 4w ago
Aster DM Healthcare Ltd provided an update on the Scheme of Amalgamation, including the effective date, change in promoter category, and amended MOA & AOA.
BSE · Company Update·1 Jul · 4w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

